• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义领域:为 OMERACT 核心结局集的基础领域制定基于共识的定义。

Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets.

机构信息

Faculty of Medicine, University of Ottawa and Ottawa Hospital Research Institute, Centre for Practice Changing Research, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.

Sydney Musculoskeletal Health, The University of Sydney and Sydney Local Health District, Sydney, Australia.

出版信息

Semin Arthritis Rheum. 2024 Jun;66:152423. doi: 10.1016/j.semarthrit.2024.152423. Epub 2024 Feb 29.

DOI:10.1016/j.semarthrit.2024.152423
PMID:38460282
Abstract

OBJECTIVE

To develop a set of detailed definitions for foundational domains commonly used in OMERACT (Outcome Measures in Rheumatology) core domain sets.

METHODS

We identified candidate domain definitions from prior OMERACT publications and websites and publications of major organizations involved in outcomes research for six domains commonly used in OMERACT Core Domain Sets: pain intensity, pain interference, physical function, fatigue, patient global assessment, and health-related quality of life. We conducted a two-round survey of OMERACT working groups, patient research partners, and then the OMERACT Technical Advisory Group to establish their preferred domain definitions. Results were presented at the OMERACT 2023 Methodology Workshop, where participants discussed their relevant lived experience and identified potential sources of variability giving the needed detail in our domain definitions.

RESULTS

One-hundred four people responded to both rounds of the survey, and a preferred definition was established for each of the domains except for patient global assessment for which no agreement was reached. Seventy-five participants at the OMERACT 2023 Methodology Workshop provided lived experience examples, which were used to contextualise domain definition reports for each of the five domains.

CONCLUSION

Using a consensus-based approach, we have created a detailed definition for five of the foundational domains in OMERACT core domain sets; patient global assessment requires further research. These definitions, although not mandatory for working groups to use, may facilitate the initial domain-match assessment step of instrument selection, and reduce the time and resources required by future OMERACT groups when developing core outcome sets.

摘要

目的

为 OMERACT(风湿病结局测量)核心域集中常用的基础域制定一套详细的定义。

方法

我们从 OMERACT 的先前出版物和网站以及参与结局研究的主要组织的出版物中确定了候选域定义,这些域适用于 OMERACT 核心域集中的六个常用域:疼痛强度、疼痛干扰、身体功能、疲劳、患者总体评估和健康相关生活质量。我们对 OMERACT 工作组、患者研究伙伴进行了两轮调查,然后对 OMERACT 技术咨询小组进行了调查,以确定他们首选的域定义。结果在 OMERACT 2023 年方法学研讨会上进行了介绍,与会者讨论了他们的相关生活经验,并确定了潜在的变异性来源,为我们的域定义提供了所需的细节。

结果

共有 104 人对两轮调查做出了回应,除了没有达成一致意见的患者总体评估之外,每个域都建立了首选定义。在 OMERACT 2023 年方法学研讨会上,75 名参与者提供了生活经验实例,这些实例用于为五个域中的每个域的域定义报告提供背景。

结论

我们使用基于共识的方法为 OMERACT 核心域集中的五个基础域创建了详细的定义;患者总体评估需要进一步研究。这些定义虽然不是工作组必须使用的,但可以促进仪器选择的初始域匹配评估步骤,并减少未来 OMERACT 小组在开发核心结局集时所需的时间和资源。

相似文献

1
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets.定义领域:为 OMERACT 核心结局集的基础领域制定基于共识的定义。
Semin Arthritis Rheum. 2024 Jun;66:152423. doi: 10.1016/j.semarthrit.2024.152423. Epub 2024 Feb 29.
2
Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases.骨关节炎疗效评价研究协会(OMERACT)制定的糖皮质激素作用核心评价指标集在风湿和肌肉骨骼疾病人群中的定义的共识。
Semin Arthritis Rheum. 2024 Feb;64:152338. doi: 10.1016/j.semarthrit.2023.152338. Epub 2023 Dec 16.
3
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.在风湿病临床试验中,关于 OMERACT 核心结局集共享决策干预领域的定义和描述的共识。
Semin Arthritis Rheum. 2024 Apr;65:152381. doi: 10.1016/j.semarthrit.2024.152381. Epub 2024 Jan 15.
4
Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.根据 OMERACT 筛选器 2.1 选择核心领域集:OMERACT 方法。
J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15.
5
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group.定义 OMERACT 幼年特发性关节炎(JIA)核心领域集中患者整体健康和疾病活动的感知:来自 JIA 工作组的报告。
Semin Arthritis Rheum. 2024 Feb;64:152340. doi: 10.1016/j.semarthrit.2023.152340. Epub 2023 Nov 30.
6
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.纳入患者视角以改善糖皮质激素治疗的获益-风险评估:OMERACT 糖皮质激素核心域集。
Semin Arthritis Rheum. 2021 Oct;51(5):1139-1145. doi: 10.1016/j.semarthrit.2021.06.010. Epub 2021 Jun 25.
7
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.如何为临床试验选择核心结局指标集:OMERACT 11批准了筛选标准2.0。
J Rheumatol. 2014 May;41(5):1025-30. doi: 10.3899/jrheum.131314. Epub 2014 Mar 1.
8
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.更新银屑病关节炎(PsA)核心领域集:来自 2016 年 OMERACT 会议上的 PsA 研讨会的报告。
J Rheumatol. 2017 Oct;44(10):1522-1528. doi: 10.3899/jrheum.160904. Epub 2017 Feb 1.
9
The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis.骨关节炎疗效评价研究协会-国际骨与关节研究协会髋关节和(或)膝关节骨关节炎临床试验测量的核心领域集。
J Rheumatol. 2019 Aug;46(8):981-989. doi: 10.3899/jrheum.181194. Epub 2019 Jan 15.
10
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus.急性焦磷酸钙晶体关节炎研究的核心领域集:建立共识的OMERACT德尔菲调查
Semin Arthritis Rheum. 2025 Jun;72:152670. doi: 10.1016/j.semarthrit.2025.152670. Epub 2025 Feb 24.

引用本文的文献

1
Weight loss, disease activity, and patient reported outcomes in patients with musculoskeletal and autoimmune diseases taking weight loss medications: a retrospective cohort study.服用减肥药物的肌肉骨骼和自身免疫性疾病患者的体重减轻、疾病活动度及患者报告结局:一项回顾性队列研究
Semin Arthritis Rheum. 2025 Jul 16;74:152783. doi: 10.1016/j.semarthrit.2025.152783.
2
Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry.根据诊断后的时间以及抗合成酶自身抗体的阳性情况分析特发性炎性肌病患者的疾病活动度:来自西班牙肌病注册研究的数据
Arthritis Res Ther. 2025 Jan 8;27(1):5. doi: 10.1186/s13075-024-03471-x.
3
Defining and measuring long COVID fatigue: a scoping review.
定义和测量新冠后疲劳:一项范围综述
BMJ Open. 2024 Dec 11;14(12):e088530. doi: 10.1136/bmjopen-2024-088530.
4
Somatosensory processing in long COVID fatigue and its relations with physiological and psychological factors.长新冠疲劳中的躯体感觉处理及其与生理和心理因素的关系。
Exp Physiol. 2024 Oct;109(10):1637-1649. doi: 10.1113/EP091988. Epub 2024 Aug 6.